Description
Tesamorelin + Ipamorelin is a two-peptide research blend in one vial: tesamorelin 13 mg and ipamorelin 3 mg, 16 mg in total. It combines a stabilized GHRH(1-44) analog with a selective ghrelin-receptor (GHS-R1a) agonist for studies of GHRH and ghrelin-receptor signaling together.
Tesamorelin + Ipamorelin Research Details
Tesamorelin is a GHRH(1-44) analog with an N-terminal trans-3-hexenoyl group for stability; ipamorelin is a selective GHS-R1a agonist. Together they are used to study the two main receptor inputs to pituitary growth hormone release and the GH/IGF-1 axis.
Independent lab report not yet posted for this product (tested lots are listed on our Lab Results page)
Tesamorelin 13 mg · Ipamorelin 3 mg
Lyophilized powder
Laboratory research only
Research Background
Key OneBio research contexts include GHRH and GHS-R receptor assays, secretagogue combination studies, GH/IGF-1 axis research and metabolic endpoint studies.
Specifications
| Compound | Tesamorelin + Ipamorelin |
| Vial Size | 16 mg (blend) |
| CAS Number | Blend (see components) |
| Molecular Formula | Blend |
| Molecular Weight | Blend |
| Identifier | Tesamorelin 218949-48-5 · Ipamorelin 170851-70-4 |
| Storage | -4°F long-term; 35-46°F short-term refrigerated; keep sealed, dry and away from light |
Quality Verification
Where an independent third-party lab report is available for a lot, it is posted on our Lab Results page and matched to the lot number on the vial. Each report covers only the lot that was tested. Contact us with your lot number to ask about documentation for your vial.
Handling
Handle only in a qualified laboratory under your institution’s validated protocols. Keep cold-chain handling and avoid repeated freeze-thaw cycles.

Reviews
There are no reviews yet.